Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCVAC/OvCa + Chemotherapy in Relapsed Platinum-Resistant Ovarian Cancer
NCT02107378Phase 2Terminated
- Sponsor
- SOTIO Biotech
- Start
- Jan 2014
- Primary completion
- Aug 2016
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 3
01
Overview
A Phase 2 trial of DCVAC/OvCa in epithelial ovarian carcinoma (EOC), sponsored by SOTIO Biotech. Started Jan 2014; status: terminated.
02
Drugs
DCVAC/OvCa
03
Conditions
epithelial ovarian carcinoma (EOC)
Beyond the preview
Go deeper on NCT02107378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107378.